ANS is focused on developing and utilizing new scientific knowledge and engineering technology to address the complex physiological, medical and societal problems presented by neurological disability. Its research agenda is at the intersection between bioengineering, neuroscience and rehabilitation.
The research of our group interfaces with biomedical engineering, nanobiotechnology, electrochemistry, BioMEMS, biochemistry, nanomedicine, surface science, and materials science. The work done here looks ahead to the next generation of nanoelectrical components such as protein nanowires, DNA transistors as well as end use electronic devices such as Lab-on-Chip, biosensors and enzymatic biofuel cells.
The main focus of the laboratory is on the mechanisms that regulate blood flow and pressure in the human body. We investigate the physiology of the microcirculation through the parallel development of theoretical and experimental models. Mathematical modeling guides experimentation and assist in data analysis while in vitro experimental studies provide important modeling parameters and promote further model development.
(OIL) focuses on optical imaging instrumentation, tomography studies with various biomedical applications such as breast cancer imaging and functional brain mapping.
TEMIM stands for “Tissue Engineered Mechanics, Imaging and Materials”. The primary research interests of the lab are in: Heart valve tissue engineering, cardiovascular mechanobiology and Evaluation of functionality and hemocompatibility of cardiovascular devices (such as stents and heart valve prosthetics).
The primary research interest of the Neuronal Mass Dynamics (NMD) laboratory is the development of methods for the integration of different brain imaging modalities. These methods will found direct translations into clinical practice, for instance in the diagnosis and intervention of a variety of brain disorders.